Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
Blood
|
March 15, 1997
Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia
S K Parsons, S X Skapek, E J Neufeld, et al.
Journal of Thrombosis and Haemostasis : JTH
|
September 3, 2011
The use of a single von Willebrand factor-containing, plasma-derived FVIII product in hemophilia A immune tolerance induction: the US experience
M Kurth, J Puetz, P Kouides, et al.
British Journal of Haematology
|
June 14, 2001
A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine-responsive megaloblastic anaemia, diabetes and deafness syndrome
S Gritli, S Omar, E Tartaglini, et al.
Cancer Research
|
December 22, 1999
The CCAAT displacement protein/cut homeodomain protein represses osteocalcin gene transcription and forms complexes with the retinoblastoma protein-related protein p107 and cyclin A
M F van Gurp, J Pratap, M Luong, et al.
Bone Marrow Transplantation
|
May 22, 2012
Pre-transplantation iron chelation in patients with MDS or acute leukemia and iron overload undergoing myeloablative allo-SCT
P Armand, M-M Sainvil, H T Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 15, 1996
CDP/cut is the DNA-binding subunit of histone gene transcription factor HiNF-D: a mechanism for gene regulation at the G1/S phase cell cycle transition point independent of transcription factor E2F
A J van Wijnen, M F van Gurp, M C de Ridder, et al.
American Journal of Hematology
|
November 10, 2010
Quality of life in thalassemia: a comparison of SF-36 results from the thalassemia longitudinal cohort to reported literature and the US norms
A Sobota, R Yamashita, Y Xu, et al.
Thrombosis and Haemostasis
|
June 13, 2014
Rituximab for treatment of inhibitors in haemophilia A. A Phase II study
C Leissinger, C D Josephson, S Granger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
August 18, 2017
Immunogenicity, efficacy and safety of Nuwiq<sup>®</sup> (human-cl rhFVIII) in previously untreated patients with severe haemophilia A-Interim results from the NuProtect Study
R J Liesner, M Abashidze, O Aleinikova, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
Blood
|
March 15, 1997
Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia
S K Parsons, S X Skapek, E J Neufeld, et al.
Journal of Thrombosis and Haemostasis : JTH
|
September 3, 2011
The use of a single von Willebrand factor-containing, plasma-derived FVIII product in hemophilia A immune tolerance induction: the US experience
M Kurth, J Puetz, P Kouides, et al.
British Journal of Haematology
|
June 14, 2001
A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine-responsive megaloblastic anaemia, diabetes and deafness syndrome
S Gritli, S Omar, E Tartaglini, et al.
Cancer Research
|
December 22, 1999
The CCAAT displacement protein/cut homeodomain protein represses osteocalcin gene transcription and forms complexes with the retinoblastoma protein-related protein p107 and cyclin A
M F van Gurp, J Pratap, M Luong, et al.
Bone Marrow Transplantation
|
May 22, 2012
Pre-transplantation iron chelation in patients with MDS or acute leukemia and iron overload undergoing myeloablative allo-SCT
P Armand, M-M Sainvil, H T Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 15, 1996
CDP/cut is the DNA-binding subunit of histone gene transcription factor HiNF-D: a mechanism for gene regulation at the G1/S phase cell cycle transition point independent of transcription factor E2F
A J van Wijnen, M F van Gurp, M C de Ridder, et al.
American Journal of Hematology
|
November 10, 2010
Quality of life in thalassemia: a comparison of SF-36 results from the thalassemia longitudinal cohort to reported literature and the US norms
A Sobota, R Yamashita, Y Xu, et al.
Thrombosis and Haemostasis
|
June 13, 2014
Rituximab for treatment of inhibitors in haemophilia A. A Phase II study
C Leissinger, C D Josephson, S Granger, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
August 18, 2017
Immunogenicity, efficacy and safety of Nuwiq<sup>®</sup> (human-cl rhFVIII) in previously untreated patients with severe haemophilia A-Interim results from the NuProtect Study
R J Liesner, M Abashidze, O Aleinikova, et al.
Page
of 8